Form 8-K - Current report:
SEC Accession No. 0001193125-21-233219
Filing Date
2021-08-02
Accepted
2021-08-02 16:06:08
Documents
3
Period of Report
2021-08-02
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d198848d8k.htm 8-K 19409
2 EX-3.1 d198848dex31.htm EX-3.1 70981
3 EX-3.2 d198848dex32.htm EX-3.2 117887
  Complete submission text file 0001193125-21-233219.txt   209396
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40671 | Film No.: 211136059
SIC: 2834 Pharmaceutical Preparations